1. Нероев В.В. Инвалидность по зрению в Российской Федерации // Российский офтальмологический конгресс «Белые Ночи»: тез. докл., СПб., 28–30 мая 2017 г. Санкт-Петербург, 2017. http://glaucoma.eye-portal.ru/neroev-vv-disability-in-sight-in-russian-federation.
2. Новик А.А., Ионова Т.И. Руководство по исследованию качества жизни в медицине. 2-е изд. М.: ОЛМА Медиа групп, 2007. 320 с.
3. Статистика: Продолжительность жизни в России. https://ruxpert.ru/ Статистика: Продолжительность_жизни_в_России.
4. Coleman D.J., Silverman R.H., Rondeau M.J., Lloyd H.O., Khanifar A.A., Chan R.V. Age-related macular degeneration: choroidal ischaemia? // Br. J. Ophthalmol. 2013. 97. (8). 1020–1029.
5. Coscas G., de Benedetto U., Coscas F., Li Calzi C.I., Vismara S., Roudot-Thoraval F., Bandello F., Souied E. Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration // Ophthalmologica. 2013. 229. (1). 32–37.
6. Cuellar-Partida G., Craig J., Burdon K.P., Wang J.J., Vote B.J., Souzeau E., McAllister I.L., Isaacs T., Lake S., Mackey D.A., Constable I.J., Mitchell P., Hewitt A.W., MacGregor S. Assessment of polygenic effects links primary open-angle glaucoma and age-related macular degeneration // Sci. Rep. 2016. 6. 26885.
7. Feigl B. Age-related maculopathy – Linking aetiology and pathophysiological changes to the ischaemia hypothesis // Prog. Retin. Eye Res. 2009. 28. (1). 63–86.
8. Garner A., Sarks A., Sarks J.P. Degenerative and related disorders of the retina and choroids // Pathobiology of ocular disease, 2nd ed. / Ed. M. Dekker. N.Y., 1994. 631–674.
9. Griffith J., Goldberg J. Prevalence of comorbid retinal disease in patients with glaucoma at an academic medical center // Clin. Ophthalmol. 2015. 9. 1275–1283.
10. Harrabi H., Kergoat M.J., Rousseau J., Boisjoly H., Schmaltz H., Moghadaszadeh S., Roy-Gagnon M.H., Freeman E.E. Age-related eye disease and cognitive function // Invest. Ophthalmol. Vis. Sci. 2015. 56. (2). 1217–1221.
11. Harwerth R., Wheat J., Rangaswamy N. Age-related losses of retinal ganglion cells and axons // Invest. Ophthalmol. Vis. Sci. 2008. 49. (10). 37–44.
12. Hochberg C., Maul E., Chan E.S., Van Landingham S., Ferrucci L., Friedman D.S., Ramulu P.Y. Association of vision loss in glaucoma and age-related macular degeneration with IADL disability // Invest. Ophthalmol. Vis. Sci. 2012. 53. (6). 32–38.
13. Hu C., Ho J., Lin H., Kao L. Association between open-angle glaucoma and neovascular age-related macular degeneration: a case-control study // Eye. 2017. 31. (6). 872–877.
14. Kashiwagi K., Iizuka Y., Tanaka Y., Araie M., Suzuki Y., Tsukahara S. Molecular and cellular reactions of retinal ganglion cells and retinal glial cells under centrifugal force loading // Invest. Ophthalmol. Vis. Sci. 2004. 45. (10). 3778–3786.
15. Krueger D., Milton R., Maunder L. The Framingham eye study: Introduction to the monograph //Surv. Ophthalmol. 1980. 24. (6). 614–620.
16. Masuzzo A., Dinet V., Cavanagh C., Mascarelli F., Krantic S. Amyloidosis in retinal neurodegenerative diseases // Front. Neurol. 2016. 7. 127.
17. Medeiros N.E., Curcio C.A. Preservation of ganglion cell layer neurons in age-related macular degeneration // Invest. Ophthalmol. Vis. Sci. 2001. 42. (3). 795–803.
18. Morgan J. Optic nerve head structure in glaucoma: Astrocytes as mediators of axonal damage //Eye. 2000. 14. (3b). 437–444.
19. Prins D., Hanekamp S., Cornelissen F. Structural brain MRI studies in eye diseases: are they clinically relevant? A review of current findings // Acta Ophthalmol. 2015. 94. (2). 113–121.
20. Prokofyeva E., Zrenner E. Epidemiology of major eye diseases leading to blindness in Europe: A literature review // Ophthalmic Res. 2012. 47. (4). 171–188.
21. Remsch H., Spraul C., Lang G., Lang G. Changes of retinal capillary blood flow in age-related maculopathy // Graefe’s Arch. Clin. Exp. Ophthalmol. 2000. 238. (12). 960–964.
22. Rimayanti U., Kiuchi Y., Yamane K. et al. Inner retinal layer comparisons of eyes with exudative age-related macular degeneration and eyes with age-related macular degeneration and glaucoma // Graefe’s Arch. Clin. Exp. Ophthalmol. 2013. 252. (4). 563–570.
23. Tan O., Chopra V., Lu A.T., Schuman J.S., Ishikawa H., Wollstein G., Varma R., Huang D. Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography // Ophthalmology. 2009. 116. (12). 2305–2314.
24. Taylor H. The global issue of vision loss and what we can do about it // Asia Pac. J. Ophthalmo.l (Phila.). 2016. 5. (2). 95–96.
25. Umfress A., Brantley M. Eye care disparities and health-related consequences in elderly patients with age-related eye disease // Semin. Ophthalmol. 2016. 31. (4). 432–438.
26. Velpandian T., Nath M., Halder N. Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy // Indian J. Ophthalmol. 2017. 65. (3). 191–198.
27. Wong W., Su X., Li X., Cheung C.M., Klein R., Cheng C.Y., Wong T.Y. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis // Lancet Glob. Health. 2014. 2. (2). e106-e 116.
28. Zheng Y., Wu X., Lin X., Lin H. The prevalence of depression and depressive symptoms among eye disease patients: A systematic review and metaanalysis // Sci. Rep. 2017. 7. 453–464.
29. Zucchiatti I., Parodi M., Pierro L., Cicinelli M.V., Gagliardi M., Castellino N., Bandello F. Macular ganglion cell complex and retinal nerve fiber layer comparison in different stages of age-related macular degeneration // Am. J. Ophthalmol. 2015. 160. (3). 602–607.